HEMOdynamic guidance with CardioMEMS in LVAD patients
Recruiting
- Registration Number
- NL-OMON24459
- Lead Sponsor
- Erasmus MC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•Signed Informed Consent Form (ICF)
Exclusion Criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study:
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To investigate the effectiveness and potential of the hybrid construction between CardioMEMS PA senseor and HeartMate-III LVAD device<br /><br><br /><br>The number of HF hospitalizations<br><br>
- Secondary Outcome Measures
Name Time Method Post-hoc analyses will be performed to study pulmonary hypertension and its potential reversibility during LVAD treatment. Additionally, we will study heart rate detection with cardioMEMS during LVAD treatment and the incidence of VTs. Additionally, we will study renal function and urinary measurements during follow-up with LVAD treatment in relation to PA pressure, and Rv function.